,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,11,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line,Confirmatory,,
6,15,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
7,17,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line,Confirmatory,,
8,19,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
9,21,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
10,23,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
11,25,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
12,27,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line,Confirmatory,,
13,29,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
14,31,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Confirmatory,,
15,33,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
16,35,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
17,37,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
18,39,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
19,41,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line,Confirmatory,,
20,43,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line,Confirmatory,,
21,45,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
22,47,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
23,49,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
24,53,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
25,55,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
26,59,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
27,61,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line,Confirmatory,,
28,63,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line,Confirmatory,,
29,65,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
30,67,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
31,69,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line,Confirmatory,,
32,71,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
33,73,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
34,75,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line,Confirmatory,,
35,77,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
36,79,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
37,81,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
38,83,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line,Confirmatory,,
39,85,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line,Confirmatory,,
40,87,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line,Confirmatory,,
41,89,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line,Confirmatory,,
42,91,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line,Confirmatory,,
43,95,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line,Confirmatory,,
44,99,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
45,101,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
46,105,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
47,107,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
48,109,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
49,113,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
50,115,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
51,119,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
52,121,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
53,123,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
54,125,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
55,129,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
56,131,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
57,133,1,1,,122585,23205,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
58,137,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Confirmatory,,
59,139,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
60,141,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
61,143,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
62,145,1,1,,122585,23205,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
63,155,1,1,,122585,23205,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
64,157,1,1,,122585,23205,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
65,161,1,1,,122585,23205,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
66,165,1,1,,122585,23205,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
67,167,1,1,,122585,23205,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
68,175,1,1,,122585,23205,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
69,179,1,1,,122585,23205,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
70,192,1,1,,122585,23205,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
71,248,1,1,,122585,23205,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
72,256,1,1,,122585,23205,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
73,328,1,1,,122585,23205,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
74,330,1,1,,122585,23205,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
75,781,1,1,,26725306,23205,Inactive,27807367.0,287022.0,,,uHTS for 14-3-3/Bad interaction inhibitors,Screening,,
76,782,1,2,,26725306,23205,Inactive,83627717.0,13684.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
77,782,1,2,,26725306,23205,Inactive,302699239.0,1981.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
78,798,2,12,,26725306,23205,Inactive,180352.0,,,,Factor XIa 1536 HTS,Screening,,
79,800,2,11,,26725306,23205,Inactive,317373446.0,2161.0,,,Factor XIIa 1536 HTS,Screening,,
80,873,1,13,,26725306,23205,Inactive,6912644.0,25818.0,,,Kallikrein 5 1536 HTS,Screening,,
81,880,2,1,,26725306,23205,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
82,880,2,1,,26725306,23205,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
83,880,2,1,,26756790,23205,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
84,880,2,1,,26756790,23205,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
85,940,1,2,,26725306,23205,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
86,1021,1,1,,26725306,23205,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Bid interaction inhibitors,Screening,,
87,1022,1,1,,26725306,23205,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Noxa interaction inhibitors,Screening,,
88,1030,2,1,,26756790,23205,Inconclusive,30582681.0,216.0,25.1189,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
89,1046,1,6,,26725306,23205,Inactive,339641.0,2147.0,,,Thrombin 1536 HTS,Screening,,
90,1085,1,1,,26725306,23205,Inactive,139424501.0,5176170.0,,,uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors,Screening,,
91,1230,1,3,,26725306,23205,Active,89993689.0,4193.0,,,E3 Ligase HTS_1536,Screening,,
92,1236,1,1,,26725306,23205,Inactive,1628587.0,397393.0,,,uHTS for Calpain Inhibitors,Screening,,
93,1242,1,1,,26725306,23205,Inactive,11094021.0,,,,C. albicans biofilm killing---Mixture HTS,Screening,,
94,1274,1,2,,26725306,23205,Inactive,115298672.0,653361.0,,,"uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs)",Screening,,
95,1376,1,2,,26725306,23205,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
96,1377,1,1,,26725306,23205,Active,,,,,HTS to identify inhibitors of zVAD Induced Cell Death in L929 Cells.,Screening,,
97,1381,1,1,,26725306,23205,Active,,,,,HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules.,Screening,,
98,1385,2,2,,26725306,23205,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
99,1394,2,2,,26725306,23205,Active,89993689.0,4193.0,0.42,EC50,E3 Ligase dose-response_384,Confirmatory,,
100,1415,1,2,,26725306,23205,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
101,1415,1,2,,26725306,23205,Inactive,86301151.0,5999.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
102,1422,1,1,,26725306,23205,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
103,1423,1,2,,26725306,23205,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
104,1423,1,2,,26725306,23205,Inactive,74355113.0,85397.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
105,1430,1,1,,26725306,23205,Inactive,70832125.0,3663016.0,,,HTS assay for inhibitors of Trypanosoma brucei hexokinase 1,Screening,,
106,1434,2,3,,26725306,23205,Inactive,13124881.0,865.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
107,1434,2,3,,26725306,23205,Inactive,19923198.0,861.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
108,1439,1,1,,26725306,23205,Inconclusive,1166512.0,6000.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
109,1439,1,1,,26725306,23205,Inconclusive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
110,1440,1,1,,26725306,23205,Inconclusive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
111,1440,1,1,,26725306,23205,Inconclusive,86990435.0,10287.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
112,1441,1,1,,26725306,23205,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
113,1441,1,1,,26725306,23205,Inactive,156416009.0,6004.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
114,1442,1,1,,26725306,23205,Active,89993689.0,4193.0,1.11,Mean Mutant EC50,E3 Ligase_Mutant_Dose Response,Confirmatory,,
115,1443,1,3,,26725306,23205,Active,4507593.0,8743.0,,,uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells,Screening,,
116,1444,1,1,,26725306,23205,Active,89993689.0,4193.0,0.18,Mean Wild-type EC50,E3 Ligase_WT_Dose Response,Confirmatory,,
117,1445,1,1,,26725306,23205,Inactive,124512980.0,813945.0,,IC50,Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP),Confirmatory,,
118,1447,1,3,,26725306,23205,Active,,,,,Identification of compounds which are cytotoxic to PPC-1 cells.,Screening,,
119,1454,1,1,,26725306,23205,Inconclusive,66932916.0,5594.0,31.6228,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
120,1456,1,1,,26725306,23205,Inactive,12003227.0,57468.0,,,Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen,Other,,
121,1457,1,1,,26756790,23205,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
122,1458,1,1,,26756790,23205,Inactive,10937869.0,6607.0,0.0056,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
123,1460,1,3,,26725306,23205,Active,92096784.0,4137.0,3.5481,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
124,1460,1,3,,26756790,23205,Inconclusive,92096784.0,4137.0,12.5893,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
125,1461,1,2,,26725306,23205,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
126,1463,1,1,,26725306,23205,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
127,1463,1,1,,26756790,23205,Active,,,8.9125,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
128,1465,1,1,,26725306,23205,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
129,1467,1,3,,26725306,23205,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
130,1468,1,1,,26725306,23205,Active,92096784.0,4137.0,3.9811,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
131,1468,1,1,,26756790,23205,Inconclusive,92096784.0,4137.0,39.8107,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
132,1469,1,1,,26725306,23205,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
133,1469,1,1,,26756790,23205,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
134,1471,2,1,,26725306,23205,Inconclusive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
135,1471,2,1,,26756790,23205,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
136,1477,1,1,,26725306,23205,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
137,1479,1,2,,26725306,23205,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
138,1479,1,2,,26756790,23205,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
139,1490,2,1,,26725306,23205,Active,10954339.0,,79.4328,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
140,1490,2,1,,26756790,23205,Inconclusive,10954339.0,,89.1251,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
141,1496,1,4,,26725306,23205,Inactive,13124881.0,865.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
142,1496,1,4,,26725306,23205,Inactive,19923198.0,861.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
143,1511,1,3,,26725306,23205,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
144,1529,1,1,,26725306,23205,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
145,1530,1,1,,26725306,23205,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
146,1531,1,1,,26725306,23205,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
147,1532,1,1,,26725306,23205,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
148,1533,1,1,,26725306,23205,Inactive,15610402.0,888704.0,,,Rml C and D inhibition 384-well mixture HTS from 1536-well compound plates,Screening,,
149,1533,1,1,,26725306,23205,Inactive,15610601.0,887352.0,,,Rml C and D inhibition 384-well mixture HTS from 1536-well compound plates,Screening,,
150,1554,1,1,,26725306,23205,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
151,1565,2,2,,26725306,23205,Inactive,219689097.0,162466.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1,Confirmatory,,
152,1566,2,3,,26725306,23205,Inactive,11545912.0,64127.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD2,Confirmatory,,
153,1578,3,2,,26725306,23205,Inactive,5174617.0,10392.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD1,Confirmatory,,
154,1619,1,2,,26725306,23205,Inactive,124809582.0,812021.0,,IC50,Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP),Confirmatory,,
155,1621,1,2,,26725306,23205,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
156,1626,1,2,,26725306,23205,Active,,,3.843,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
157,1631,3,1,,26725306,23205,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
158,1634,3,1,,26725306,23205,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
159,1654,2,2,,26725306,23205,Inactive,4758208.0,1845.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit VHR1.,Confirmatory,,
160,1656,2,2,,26725306,23205,Inactive,,,,,High Throughput Imaging Assay for Hepatic Lipid Droplet Formation,Screening,,
161,1662,1,2,,26725306,23205,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
162,1663,1,2,,26725306,23205,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
163,1665,2,2,,26725306,23205,Inactive,4503131.0,1499.0,,IC50_Mean,High Throughput Imaging Assay for Beta-Catenin,Confirmatory,,
164,1672,1,3,,26725306,23205,Active,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
165,1688,1,1,,26725306,23205,Active,90903231.0,3064.0,2.2387,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
166,1721,1,2,,26725306,23205,Inactive,290753097.0,,,Potency,qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
167,1722,1,2,,26725306,23205,Inactive,290753097.0,,,Potency,qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
168,1766,1,1,,26725306,23205,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
169,1766,1,1,,26725306,23205,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
170,1775,1,2,,26725306,23205,Inactive,,,,,Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission,Other,,
171,1777,3,2,,26725306,23205,Inactive,39725940.0,4986.0,,EC50,uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
172,1778,3,3,,26725306,23205,Inactive,39725940.0,4986.0,,IC50,uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
173,1779,2,2,,26725306,23205,Inactive,224586929.0,26191.0,,IC50,uHTS identification of small molecule inhibitors of LYP via a fluorescence intensity assay,Confirmatory,,
174,1813,1,2,,26725306,23205,Active,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
175,1814,1,2,,26725306,23205,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
176,1817,2,2,,26725306,23205,Inactive,40849930.0,5339.0,,IC50,uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay.,Confirmatory,,
177,1832,2,1,,26725306,23205,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
178,1850,2,1,,26725306,23205,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
179,1852,1,2,,26725306,23205,Active,25952111.0,7124.0,,,HTS assay for identification of inhibitors of TNF-a-specific NF-kB induction,Other,,
180,1863,2,1,,26725306,23205,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
181,1865,1,1,,26725306,23205,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
182,1865,1,1,,26756790,23205,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
183,1868,1,4,,26725306,23205,Inactive,4503895.0,2584.0,,Potency,qHTS Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
184,1875,2,1,,26725306,23205,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
185,1885,2,1,,26725306,23205,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
186,1899,1,3,,26725306,23205,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
187,1903,2,3,,26725306,23205,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
188,1906,1,3,,26725306,23205,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
189,1910,1,2,,26725306,23205,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
190,1947,1,2,,26725306,23205,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
191,1950,1,3,,26725306,23205,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
192,1956,1,1,,26725306,23205,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
193,1961,2,2,,26725306,23205,Inactive,33695107.0,9290.0,,EC50,Image-based HTS for Selective Agonists of GPR55,Confirmatory,,
194,1962,1,2,,26725306,23205,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
195,1974,1,2,,26725306,23205,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
196,1984,1,3,,26725306,23205,Inactive,118026946.0,17979.0,,IC50,Fluorescence for the identification of compounds that decrease p/CIP protein stability,Confirmatory,,
197,1986,1,2,,26725306,23205,Inactive,45357394.0,,,IC50,uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors.,Confirmatory,,
198,1987,1,2,,26725306,23205,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
199,1988,1,2,,26725306,23205,Inconclusive,,,,EC50,Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells,Confirmatory,,
200,1990,1,2,,26725306,23205,Inconclusive,,,4.625,EC50,Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells,Confirmatory,,
201,1994,1,2,,26725306,23205,Active,,,8.316,EC50,Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4 Neuroglioblastoma Cells,Confirmatory,,
202,2006,3,2,,26725306,23205,Inactive,4507785.0,7329.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
203,2006,3,2,,26725306,23205,Inactive,13111961.0,10054.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
204,2006,3,2,,26725306,23205,Inactive,17390638.0,10055.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
205,2012,3,2,,26725306,23205,Inactive,45219878.0,7458.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H),Confirmatory,,
206,2013,2,2,,26725306,23205,Active,33695107.0,9290.0,2.64228,IC50,Image-Based HTS for Selective Antagonists for GPR55,Confirmatory,,
207,2014,3,2,,26725306,23205,Inactive,46367787.0,26986.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP),Confirmatory,,
208,2016,1,3,,26725306,23205,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
209,2023,1,3,,26725306,23205,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
210,2025,1,3,,26725306,23205,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
211,2029,1,3,,26725306,23205,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
212,2052,2,1,,26725306,23205,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
213,2057,1,2,,26725306,23205,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
214,2058,3,2,,26725306,23205,Inactive,33695097.0,2859.0,,IC50,Image-Based HTS for Selective Antagonists of GPR35,Confirmatory,,
215,2066,1,4,,26725306,23205,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
216,2071,2,2,,26725306,23205,Inactive,14719829.0,22861.0,,,Colorimetric  Assay for Inhibitors for NALP1,Screening,,
217,2073,2,3,,26725306,23205,Inactive,2625023.0,83589.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
218,2073,2,3,,26725306,23205,Inactive,4502523.0,774.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
219,2094,1,2,,26725306,23205,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
220,2094,1,2,,26725306,23205,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
221,2094,1,2,,26725306,23205,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
222,2097,1,2,,26725306,23205,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
223,2098,1,1,,26725306,23205,Active,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
224,2099,1,1,,26725306,23205,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
225,2100,1,1,,26725306,23205,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen,Confirmatory,,
226,2101,1,1,,26725306,23205,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
227,2101,1,1,,26756790,23205,Inconclusive,496369.0,2629.0,1.5849,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
228,2107,1,1,,26725306,23205,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
229,2107,1,1,,26756790,23205,Inconclusive,757912.0,2717.0,39.8107,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
230,2112,1,1,,26725306,23205,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
231,2112,1,1,,26756790,23205,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
232,2129,1,2,,26725306,23205,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
233,2130,1,3,,26725306,23205,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
234,2147,1,1,,26725306,23205,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
235,2156,2,2,,26725306,23205,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
236,2174,1,3,,26725306,23205,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
237,2177,1,3,,26725306,23205,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
238,2216,1,3,,26725306,23205,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
239,2221,1,2,,26725306,23205,Inactive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
240,2227,1,2,,26725306,23205,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
241,2234,1,2,,26725306,23205,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
242,2235,1,2,,26725306,23205,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
243,2237,1,2,,26725306,23205,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
244,2239,1,2,,26725306,23205,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
245,2247,1,2,,26725306,23205,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
246,2280,2,3,,26725306,23205,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
247,2288,1,1,,26725306,23205,Inconclusive,,,1.3092,Potency,qHTS Assay for Modulators of miRNAs and/orActivators of miR-21,Confirmatory,,
248,2289,1,1,,26725306,23205,Inconclusive,,,1.3092,Potency,qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21,Confirmatory,,
249,2300,1,3,,26725306,23205,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
250,2314,1,2,,26725306,23205,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
251,2314,1,2,,26725306,23205,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
252,2315,1,2,,26725306,23205,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
253,2315,1,2,,26725306,23205,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
254,2326,1,1,,26725306,23205,Inconclusive,194352380.0,,4.4668,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
255,2380,1,2,,26725306,23205,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
256,2391,1,1,,26725306,23205,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
257,2435,1,2,,26725306,23205,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
258,2445,1,2,,26725306,23205,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
259,2451,1,2,,26725306,23205,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
260,2462,1,1,,26725306,23205,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
261,2462,1,1,,26725306,23205,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
262,2472,1,2,,26725306,23205,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
263,2517,2,1,,26725306,23205,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
264,2517,2,1,,26756790,23205,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
265,2520,1,4,,26725306,23205,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
266,2521,1,3,,26725306,23205,Active,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
267,2524,1,2,,26725306,23205,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
268,2528,1,2,,26725306,23205,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
269,2540,1,2,,26725306,23205,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
270,2544,1,2,,26725306,23205,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
271,2546,1,1,,26725306,23205,Active,188536040.0,19885.0,3.1623,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
272,2549,1,1,,26725306,23205,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
273,2549,1,1,,26756790,23205,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
274,2550,1,3,,26725306,23205,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
275,2551,1,1,,26725306,23205,Active,188536040.0,19885.0,3.1623,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
276,2553,1,2,,26725306,23205,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
277,2557,1,3,,26725306,23205,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
278,2563,1,1,,26725306,23205,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
279,2599,1,2,,26725306,23205,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
280,2606,1,2,,26725306,23205,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
281,2629,1,1,,26725306,23205,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
282,2642,1,2,,26725306,23205,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
283,2648,1,2,,26725306,23205,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
284,2650,2,1,,26725306,23205,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
285,2661,1,1,,26725306,23205,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
286,2662,2,1,,26725306,23205,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
287,2675,1,1,,26725306,23205,Inactive,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
288,2676,1,2,,26725306,23205,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
289,2685,1,1,,26725306,23205,Inconclusive,,,5.8048,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
290,2690,1,2,,26725306,23205,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
291,2716,1,1,,26725306,23205,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
292,2717,1,2,,26725306,23205,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
293,2718,1,1,,26725306,23205,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
294,2732,1,1,,26725306,23205,Active,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
295,2751,2,2,,26725306,23205,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
296,2766,1,2,,26725306,23205,Active,4885057.0,187.0,,,Single concentration confirmation of uHTS hits from a small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
297,2784,1,2,,26725306,23205,Inactive,4885057.0,187.0,21.3,IC50_Mean,Dose Response confirmation of uHTS hits from a small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Confirmatory,,
298,2796,1,4,,26725306,23205,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
299,2797,1,2,,26725306,23205,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
300,2805,2,2,,26725306,23205,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
301,2806,2,2,,26725306,23205,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
302,2825,1,2,,26725306,23205,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
303,50735,7,1,,103360847,23205,Active,,,,,Mean graph mid point was measured on colon cancer cells.,Other,11052798.0,
304,91673,7,1,,103360847,23205,Active,,,,,Mean graph mid point was measured on all cell lines.,Other,11052798.0,
305,99422,7,1,,103360847,23205,Active,,,,,Mean graph mid point was measured on leukemic cells.,Other,11052798.0,
306,110402,7,1,,103360847,23205,Unspecified,,,,,"Antileukemic activity of compound against the P-388 lymphocytic leukemic BDF1 male mice at 25(mg/kg)/day, administered intraperitoneally; 12.3/9.66 (Treated/control)",Other,7328595.0,
307,110406,7,1,,103360847,23205,Unspecified,,,,,"Antileukemic activity of compound against the P-388 lymphocytic leukemic BDF1 male mice at 3(mg/kg)/day, administered intraperitoneally; 12.9/9.66 (Treated/control)",Other,7328595.0,
308,110545,7,1,,103360847,23205,Unspecified,,,,,"Antileukemic activity of compound against the P-388 lymphocytic leukemic BDF1 male mice at 60 mg/kg/day, administered intraperitoneally; 3.0/9.66 (Treated/control)",Other,7328595.0,
309,110556,7,1,,103360847,23205,Unspecified,,,,,"Antileukemic activity of compound against the P-388 lymphocytic leukemic BDF1 male mice at 8(mg/kg)/day, administered intraperitoneally; 15.7/9.66 (Treated/control)",Other,7328595.0,
310,110559,7,1,,103360847,23205,Unspecified,,,,,"Antileukemic activity of compound against the P-388 lymphocytic leukemic BDF1 male mice at 15(mg/kg)/day, administered intraperitoneally; 11.9/9.66 (Treated/control)",Other,7328595.0,
311,121633,3,3,,103360847,23205,Unspecified,,,,,In vivo antileukemic activity against P-388 Lymphocytic Leukemia in BDF1 male mice at 15(mg/kg)/day intraperitoneal dose expressed as T/C,Other,7328595.0,
312,121634,3,3,,103360847,23205,Unspecified,,,,,In vivo antileukemic activity against P-388 Lymphocytic Leukemia in BDF1 male mice at 25(mg/kg)/day intraperitoneal dose expressed as T/C,Other,7328595.0,
313,121635,3,3,,103360847,23205,Unspecified,,,,,In vivo antileukemic activity against P-388 Lymphocytic Leukemia in BDF1 male mice at 60 mg/kg/day intraperitoneal dose expressed as T/C,Other,7328595.0,
314,121642,3,3,,103360847,23205,Unspecified,,,,,In vivo antileukemic activity against P-388 lymphocytic leukemia in BDF1 male mice at 3(mg/kg)/day intraperitoneal dose expressed as T/C,Other,7328595.0,
315,121648,3,3,,103360847,23205,Unspecified,,,,,In vivo antileukemic activity against P-388 lymphocytic leukemia in BDF1 male mice at 8(mg/kg)/day intraperitoneal dose expressed as T/C,Other,7328595.0,
316,174706,3,3,,103360847,23205,Unspecified,,,,,Cytoprotective effect at an oral dose of 40 mg/kg,Other,1619619.0,
317,235488,3,3,,103360847,23205,Unspecified,,,,,Selectivity index is the ratio of MG MID value for all cell lines to that of colon cancer cells,Other,11052798.0,
318,235489,3,3,,103360847,23205,Unspecified,,,,,Selectivity index is the ratio of MG MID value for all cell lines to that of leukemic cells,Other,11052798.0,
319,242927,7,1,,103360847,23205,Active,21542418.0,4790.0,,,Concentration required for complete inhibition of Nuclear factor kappa B DNA binding,Other,15537359.0,
320,242927,7,1,,103360847,23205,Active,62906901.0,5970.0,,,Concentration required for complete inhibition of Nuclear factor kappa B DNA binding,Other,15537359.0,
321,242927,7,1,,103360847,23205,Active,116242678.0,4791.0,,,Concentration required for complete inhibition of Nuclear factor kappa B DNA binding,Other,15537359.0,
322,262798,7,1,,103360847,23205,Active,62906901.0,5970.0,,,Inhibition of NF-kappaB DNA binding by EMSA,Other,16570920.0,
323,310936,6,1,,103360847,23205,Unspecified,,,,,Cytotoxicity against human KB cells,Other,17336532.0,
324,320961,6,2,,103360847,23205,Active,,,4.28,IC50,Inhibition of serotonin release in bovine platelets,Confirmatory,18271521.0,
325,335952,3,4,,103360847,23205,Active,,,,,Antiulcerogenic activity in Wistar rat assessed as cytoprotection against ethanol-induced gastric lesions at 40 mg/kg administered 60 mins before ethanol challenge,Other,2095374.0,
326,355111,3,4,,103360847,23205,Unspecified,,,,,Antineoplastic activity against mouse P388 cells at 3 mg/kg relative to control,Other,8792630.0,
327,360408,8,1,,103360847,23205,Active,,,2.5,IC50,Inhibition of TNF-induced NF-kappaB-mediated IL6 promoter expression in mouse L929sA cells by luciferase reporter gene assay,Confirmatory,17150968.0,
328,380084,6,2,,103360847,23205,Active,,,0.7,IC50,Cytotoxicity against human HL60 after 20 hrs by WST1 assay,Confirmatory,16499337.0,
329,380086,6,2,,103360847,23205,Active,,,0.46,IC50,Cytotoxicity against human Jurkat T cells after 20 hrs by WST1 assay,Confirmatory,16499337.0,
330,380087,6,2,,103360847,23205,Inconclusive,,,,IC50,Cytotoxicity against human Jurkat T cells overexpressing Bcl2 after 20 hrs by WST1 assay,Confirmatory,16499337.0,
331,380518,6,3,,103360847,23205,Active,,,0.27,IC50,Cytotoxicity against human GTB cells after 5 hrs by MTT assay,Confirmatory,10425121.0,
332,380520,6,2,,103360847,23205,Active,,,0.32,IC50,Cytotoxicity against human HL-60 cells after 5 hrs by MTT assay,Confirmatory,10425121.0,
333,380522,6,2,,103360847,23205,Active,,,0.9,IC50,Cytotoxicity against human A431 cells after 24 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
334,380523,6,2,,103360847,23205,Active,,,0.9,IC50,Cytotoxicity against human A431 cells after 48 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
335,380524,6,2,,103360847,23205,Active,,,0.8,IC50,Cytotoxicity against human A431 cells after 72 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
336,380525,6,3,,103360847,23205,Active,,,0.9,IC50,Cytotoxicity against human HEP2 cells after 24 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
337,380526,6,3,,103360847,23205,Active,,,0.9,IC50,Cytotoxicity against human HEP2 cells after 48 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
338,380527,6,3,,103360847,23205,Active,,,0.8,IC50,Cytotoxicity against human HEP2 cells after 72 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
339,380528,6,2,,103360847,23205,Active,,,0.8,IC50,Cytotoxicity against human MCF7 cells after 24 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
340,380529,6,2,,103360847,23205,Active,,,0.5,IC50,Cytotoxicity against human MCF7 cells after 48 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
341,380530,6,2,,103360847,23205,Active,,,0.7,IC50,Cytotoxicity against human MCF7 cells after 72 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
342,380531,6,2,,103360847,23205,Active,,,1.4,IC50,Cytotoxicity against human OVCAR-3 cells after 24 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
343,380532,6,2,,103360847,23205,Active,,,1.6,IC50,Cytotoxicity against human OVCAR-3 cells after 48 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
344,380533,6,2,,103360847,23205,Active,,,1.7,IC50,Cytotoxicity against human OVCAR-3 cells after 72 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
345,380534,6,3,,103360847,23205,Active,,,1.3,IC50,Cytotoxicity against human SK MEL28 cells after 24 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
346,380535,6,3,,103360847,23205,Active,,,0.9,IC50,Cytotoxicity against human SK MEL28 cells after 48 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
347,380536,6,3,,103360847,23205,Active,,,0.5,IC50,Cytotoxicity against human SK MEL28 cells after 72 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
348,380537,6,3,,103360847,23205,Active,,,1.3,IC50,Cytotoxicity against human SK37 cells after 24 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
349,380538,6,3,,103360847,23205,Active,,,1.2,IC50,Cytotoxicity against human SK37 cells after 48 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
350,380539,6,3,,103360847,23205,Active,,,0.7,IC50,Cytotoxicity against human SK37 cells after 72 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
351,380540,6,3,,103360847,23205,Active,,,1.4,IC50,Cytotoxicity against human SW872 cells after 24 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
352,380541,6,3,,103360847,23205,Active,,,1.2,IC50,Cytotoxicity against human SW872 cells after 48 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
353,380542,6,3,,103360847,23205,Active,,,1.2,IC50,Cytotoxicity against human SW872 cells after 72 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
354,380543,6,2,,103360847,23205,Active,,,0.7,IC50,Cytotoxicity against human ZR-75-1 cells after 24 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
355,380544,6,2,,103360847,23205,Active,,,0.8,IC50,Cytotoxicity against human ZR-75-1 cells after 48 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
356,380545,6,2,,103360847,23205,Active,,,1.1,IC50,Cytotoxicity against human ZR-75-1 cells after 72 hrs by [3H]thymidine incorporation assay,Confirmatory,10425121.0,
357,387024,8,1,,103360847,23205,Unspecified,,,,,Cytotoxicity against human KB cells,Other,18329753.0,
358,400914,6,2,,103360847,23205,Unspecified,,,,,Cytotoxicity against human Jurkat T cells,Other,15104480.0,
359,401842,6,3,,103360847,23205,Active,,,2.4,IC50,Cytotoxicity against mouse cloned EN2 cells after 2 hrs by MTT assay,Confirmatory,9090867.0,
360,401843,6,3,,103360847,23205,Active,,,0.39,IC50,Cytotoxicity against mouse cloned EN2 cells after 72 hrs by MTT assay,Confirmatory,9090867.0,
361,434955,1,2,,26725306,23205,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
362,434962,1,2,,26725306,23205,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
363,434973,1,3,,26725306,23205,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
364,434989,1,1,,26725306,23205,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
365,435003,1,3,,26725306,23205,Active,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
366,435005,1,1,,26725306,23205,Active,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
367,435020,1,2,,26725306,23205,Active,,,,,Single concentration confirmation of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
368,435022,2,2,,26725306,23205,Active,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
369,435030,1,2,,26725306,23205,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
370,435030,1,2,,26725306,23205,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
371,449728,1,2,,26725306,23205,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
372,449739,1,2,,26725306,23205,Inactive,53832009.0,8912.0,,,Inhibitors of Cav3 T-type Calcium Channels: Primary Screen,Screening,,
373,449746,1,2,,26725306,23205,Active,,,,,Single concentration confirmation of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
374,449756,1,1,,26725306,23205,Active,,,2.2680000000000002,AC50_uM,Luminescence Cell-Based Dose Retest to Confirm Inhibitors of  Beta Cell Apoptosis,Confirmatory,,
375,449762,1,2,,26725306,23205,Inconclusive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
376,449763,1,3,,26725306,23205,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
377,449768,1,1,,26725306,23205,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
378,463075,1,1,,26725306,23205,Active,,,,,HTS to identify inhibitors of TNF-alpha Induced Cell Death in Jurkat FADD-/- Cells.,Screening,,
379,463079,1,2,,26725306,23205,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
380,463082,1,1,,26725306,23205,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
381,463104,1,2,,26725306,23205,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
382,463111,1,1,,26725306,23205,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
383,463115,1,1,,26725306,23205,Inactive,119622516.0,5045.0,,,High throughput fluorescence intensity-based biochemical assay to screen for small molecule inhibitors of Furin conducted by the Pittsburgh Molecular Library Screening Center.,Screening,,
384,463141,1,2,,26725306,23205,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
385,463165,1,1,,26725306,23205,Active,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
386,463187,1,1,,26725306,23205,Inactive,,,,,384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC,Screening,,
387,463190,1,2,,26725306,23205,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
388,463195,1,2,,26725306,23205,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
389,463206,1,1,,26725306,23205,Inactive,,,260.0,AC50_uM,Luminescence Cell-Based Counter Screen to Identify Inhibitors of Cytokine Induced Apoptosis,Confirmatory,,
390,463210,1,2,,26725306,23205,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
391,463212,1,1,,26725306,23205,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
392,463214,1,1,,26725306,23205,Active,4501997.0,185.0,18.639,IC50,Dose Response screen for antagonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule antagonists hits of the APJ receptor,Confirmatory,,
393,463229,1,1,,26725306,23205,Active,,,2.025,AC50_uM,ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick,Confirmatory,,
394,463254,1,1,,26725306,23205,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
395,485270,1,1,,26725306,23205,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
396,485272,1,1,,26725306,23205,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
397,485273,2,1,,26725306,23205,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
398,485275,1,3,,26725306,23205,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
399,485281,1,1,,26725306,23205,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
400,485281,1,1,,26756790,23205,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
401,485290,1,1,,26725306,23205,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
402,485290,1,1,,26756790,23205,Inactive,20150581.0,,11.2202,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
403,485294,1,1,,26725306,23205,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
404,485297,1,1,,26725306,23205,Inactive,4759012.0,9367.0,1.0,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
405,485298,1,1,,26725306,23205,Inactive,,,8.9125,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
406,485313,1,2,,26725306,23205,Inactive,255652944.0,4864.0,0.7943,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
407,485314,1,1,,26725306,23205,Inconclusive,4505931.0,5423.0,100.0,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
408,485317,1,2,,26725306,23205,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
409,485341,1,1,,26725306,23205,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
410,485344,1,1,,26725306,23205,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
411,485346,1,1,,26725306,23205,Active,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
412,485346,1,1,,26725306,23205,Active,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
413,485347,1,2,,26725306,23205,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
414,485349,1,1,,26725306,23205,Inactive,71902540.0,472.0,,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
415,485350,1,2,,99300642,23205,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
416,485352,1,4,,26725306,23205,Inactive,18073591.0,,40.0,EC50,"HTS Dose response counterscreen for assays utilizing the enzyme, beta-galactosidase - Set 2",Confirmatory,,
417,485353,2,1,,26725306,23205,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
418,485358,1,1,,26725306,23205,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
419,485364,1,1,,26725306,23205,Active,15149312.0,8345881.0,25.1189,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
420,485367,1,2,,26725306,23205,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
421,488837,1,1,,26725306,23205,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
422,488839,1,1,,26725306,23205,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
423,488839,1,1,,26725306,23205,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
424,488847,1,3,,26725306,23205,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
425,488862,1,1,,26725306,23205,Active,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
426,488890,1,2,,26725306,23205,Inconclusive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
427,488895,1,2,,26725306,23205,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
428,488896,1,1,,26725306,23205,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
429,488899,1,1,,26725306,23205,Active,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
430,488922,1,2,,26725306,23205,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
431,488965,1,2,,26725306,23205,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
432,488966,1,1,,26725306,23205,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
433,488975,1,2,,26725306,23205,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
434,488977,1,2,,26725306,23205,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
435,489004,1,2,,26725306,23205,Active,,,1.02,IC50_Mean,Dose response confirmation of uHTS of chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay,Confirmatory,,
436,489019,1,2,,26725306,23205,Inactive,,,80.0,IC50_Mean,Dose response cytoxicity of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay,Confirmatory,,
437,489020,1,2,,26725306,23205,Inactive,,,80.0,IC50_Mean,Dose response counterscreen of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay,Confirmatory,,
438,489028,1,2,,26725306,23205,Active,88702791.0,4194.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
439,489028,1,2,,26725306,23205,Active,89993689.0,4193.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
440,489030,2,1,,26725306,23205,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
441,489031,2,1,,26725306,23205,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
442,489034,1,2,,26725306,23205,Inactive,,,80.0,IC50_Mean,Dose response confirmation of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay,Confirmatory,,
443,492425,9,2,,103360847,23205,Active,,,0.23,IC50,Antimalarial activity against Plasmodium falciparum,Confirmatory,19299148.0,
444,492466,3,5,,103360847,23205,Unspecified,,,,,Antitumor activity against rat Walker 256 cells allografted in rat at 2.5 mg/kg relative to control,Other,20187635.0,
445,492467,7,1,,103360847,23205,Unspecified,,,,,Cytotoxicity against human HepG2 cells,Other,20187635.0,
446,492468,3,5,,103360847,23205,Unspecified,,,,,Antitumor activity against mouse P388 cells allografted in mouse at 8 mg/kg relative to control,Other,20187635.0,
447,492947,1,1,,26725306,23205,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
448,492953,1,1,,26725306,23205,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
449,492956,1,1,,26725306,23205,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
450,492972,1,1,,26725306,23205,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
451,492999,1,1,,26725306,23205,Active,5032039.0,5999.0,,,Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4),Screening,,
452,493000,1,1,,26725306,23205,Inactive,5032039.0,5999.0,,,Counter screen for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4): Non-induced cells with the primary screen assay,Screening,,
453,493001,1,1,,26725306,23205,Inactive,5032039.0,5999.0,,,Second counter screen for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4): Non-induced cells with the primary screen assay without carbachol activation,Screening,,
454,493005,1,1,,26725306,23205,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
455,493008,1,1,,26725306,23205,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
456,493008,1,1,,26725306,23205,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
457,493008,1,1,,26725306,23205,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
458,493008,1,1,,26725306,23205,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
459,493011,1,1,,26725306,23205,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
460,493012,1,1,,26725306,23205,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
461,493014,1,1,,26725306,23205,Inconclusive,,,0.8913,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
462,493033,1,2,,99300642,23205,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
463,493036,1,2,,26725306,23205,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
464,493056,1,1,,26725306,23205,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
465,493084,1,1,,26725306,23205,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
466,493087,1,1,,26725306,23205,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
467,493091,1,1,,26725306,23205,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
468,493098,1,1,,26725306,23205,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
469,493131,1,1,,26725306,23205,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
470,493160,1,1,,26725306,23205,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
471,493187,1,2,,26725306,23205,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
472,493244,1,1,,26725306,23205,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
473,493244,1,1,,26725306,23205,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
474,493244,1,1,,26725306,23205,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
475,493244,1,1,,26725306,23205,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
476,495064,3,4,,103360847,23205,Unspecified,,,,,Inhibition of JAK-mediated GM-CSF-induced Stat5 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM,Other,18157122.0,
477,495065,3,4,,103360847,23205,Unspecified,,,,,Inhibition of JAK-mediated interferon-gamma-induced Stat1 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM,Other,18157122.0,
478,495066,3,5,,103360847,23205,Unspecified,2499600.0,1432.0,,,Inhibition of anisomycin-induced p38 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM,Other,18157122.0,
479,495066,3,5,,103360847,23205,Unspecified,2851522.0,6300.0,,,Inhibition of anisomycin-induced p38 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM,Other,18157122.0,
480,495066,3,5,,103360847,23205,Unspecified,6685642.0,5603.0,,,Inhibition of anisomycin-induced p38 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM,Other,18157122.0,
481,495066,3,5,,103360847,23205,Unspecified,134047835.0,5600.0,,,Inhibition of anisomycin-induced p38 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM,Other,18157122.0,
482,504313,1,1,,26725306,23205,Active,47678753.0,7494.0,2.43,Absolute IC50 (XBP1),XBP1 DR counterscreen for CHOP,Confirmatory,,
483,504322,1,1,,26725306,23205,Active,160707929.0,13198.0,2.61,Absolute IC50 (CHOP),CHOP dose-response primary assay,Confirmatory,,
484,504326,1,2,,26725306,23205,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
485,504326,1,2,,26725306,23205,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
486,504327,1,1,,26725306,23205,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
487,504327,1,1,,26756790,23205,Inconclusive,153791535.0,2648.0,25.1189,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
488,504329,1,1,,26725306,23205,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
489,504332,1,1,,26725306,23205,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
490,504332,1,1,,26756790,23205,Active,168985070.0,,11.2202,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
491,504333,1,1,,26725306,23205,Inactive,6683500.0,29994.0,,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
492,504339,1,1,,26725306,23205,Inactive,162330054.0,,,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
493,504357,1,1,,26725306,23205,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
494,504357,1,1,,26725306,23205,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
495,504406,1,1,,26725306,23205,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
496,504408,2,1,,26725306,23205,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
497,504411,1,1,,26725306,23205,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
498,504414,1,1,,26725306,23205,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
499,504414,1,1,,26725306,23205,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
500,504423,1,1,,26725306,23205,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
501,504437,1,1,,26725306,23205,Active,160707929.0,13198.0,,,CHOP Confirmatory Screen,Screening,,
502,504441,1,1,,26725306,23205,Inactive,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
503,504444,1,1,,26725306,23205,Active,224028257.0,4780.0,3.6626,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
504,504454,1,3,,26725306,23205,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
505,504462,1,1,,26725306,23205,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
506,504466,1,1,,26725306,23205,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
507,504467,1,1,,26725306,23205,Active,116283940.0,79915.0,4.1078,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
508,504490,1,2,,26725306,23205,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
509,504523,1,1,,26725306,23205,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
510,504523,1,1,,26725306,23205,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
511,504539,2,1,,26725306,23205,Active,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_Dose_CherryPick_Activity_Set2,Confirmatory,,
512,504558,1,1,,26725306,23205,Active,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
513,504577,2,2,,26725306,23205,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
514,504582,2,1,,26725306,23205,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
515,504592,1,1,,26725306,23205,Active,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_CherryPick_Activity,Confirmatory,,
516,504601,1,1,,26725306,23205,Active,88702791.0,4194.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format - Set 2,Screening,,
517,504601,1,1,,26725306,23205,Active,89993689.0,4193.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format - Set 2,Screening,,
518,504607,1,1,,26725306,23205,Active,,,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay,Screening,,
519,504621,1,1,,26725306,23205,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
520,504634,1,1,,26725306,23205,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
521,504648,1,1,,26725306,23205,Active,,,9.2,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
522,504651,1,1,,26725306,23205,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
523,504652,1,1,,26725306,23205,Inactive,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
524,504660,1,1,,26725306,23205,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
525,504668,1,1,,26725306,23205,Active,728984.0,672.0,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay.,Screening,,
526,504668,1,1,,26725306,23205,Active,116241265.0,580.0,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay.,Screening,,
527,504690,1,3,,26725306,23205,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
528,504692,2,2,,26725306,23205,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
529,504700,1,1,,26725306,23205,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
530,504700,1,1,,26725306,23205,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
531,504706,1,1,,26725306,23205,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
532,504707,1,1,,26725306,23205,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
533,504707,1,1,,26725306,23205,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
534,504720,1,1,,26725306,23205,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
535,504734,1,1,,26725306,23205,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
536,504766,2,1,,26725306,23205,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
537,504775,1,1,,26725306,23205,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
538,504803,1,1,,26725306,23205,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
539,504810,1,2,,26725306,23205,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
540,504812,1,2,,26725306,23205,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
541,504832,1,1,,26725306,23205,Active,,,0.8275,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
542,504834,1,1,,26725306,23205,Active,,,1.0418,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
543,504842,1,1,,26725306,23205,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
544,504845,1,1,,26725306,23205,Inconclusive,86301163.0,5999.0,50.1187,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
545,504845,1,1,,26756790,23205,Active,86301163.0,5999.0,21.1923,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
546,504847,1,1,,26725306,23205,Inconclusive,63054845.0,7421.0,39.8107,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
547,504847,1,1,,26756790,23205,Inconclusive,63054845.0,7421.0,31.6228,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
548,504848,1,1,,26725306,23205,Active,,,1.9953,Potency,"Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
549,504850,1,1,,26725306,23205,Active,,,1.5849,Potency,"Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
550,504884,1,2,,26725306,23205,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
551,504891,1,1,,26725306,23205,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
552,504894,1,1,,26725306,23205,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
553,504937,1,2,,26725306,23205,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
554,540253,1,1,,26725306,23205,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
555,540253,1,1,,26725306,23205,Inactive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
556,540253,1,1,,26725306,23205,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
557,540263,1,1,,26725306,23205,Inconclusive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
558,540263,1,1,,26725306,23205,Inconclusive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
559,540267,1,1,,26725306,23205,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
560,540275,1,1,,26725306,23205,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
561,540277,1,1,,26725306,23205,Inconclusive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
562,540295,1,1,,26725306,23205,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
563,540303,1,1,,26725306,23205,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
564,540303,1,1,,26725306,23205,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
565,540303,1,1,,26725306,23205,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
566,540308,1,1,,26725306,23205,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
567,540317,1,1,,26725306,23205,Inactive,187960037.0,10951.0,79.4328,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
568,540336,1,1,,26725306,23205,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
569,540336,1,1,,26725306,23205,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
570,540364,1,2,,26725306,23205,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
571,588334,1,1,,26725306,23205,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
572,588335,1,1,,26725306,23205,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
573,588342,1,1,,26725306,23205,Inactive,160794.0,,,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
574,588352,1,2,,26725306,23205,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
575,588354,1,1,,26725306,23205,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
576,588358,1,2,,26725306,23205,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
577,588391,1,1,,26725306,23205,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
578,588405,1,1,,26725306,23205,Active,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
579,588413,1,2,,26725306,23205,Active,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
580,588436,1,1,,26725306,23205,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
581,588453,1,1,,26725306,23205,Inconclusive,8659577.0,58819.0,56.2341,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
582,588456,1,1,,26725306,23205,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
583,588458,1,1,,26725306,23205,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
584,588473,1,1,,26725306,23205,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
585,588473,1,1,,26725306,23205,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
586,588475,1,2,,26725306,23205,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
587,588475,1,2,,26725306,23205,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
588,588478,1,2,,124801412,23205,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
589,588489,1,1,,26725306,23205,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
590,588492,1,1,,26725306,23205,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
591,588493,1,2,,26725306,23205,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
592,588497,1,2,,26725306,23205,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
593,588497,1,2,,26725306,23205,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
594,588497,1,2,,26725306,23205,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
595,588499,1,3,,26725306,23205,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
596,588499,1,3,,26725306,23205,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
597,588499,1,3,,26725306,23205,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
598,588501,1,2,,26725306,23205,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
599,588501,1,2,,26725306,23205,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
600,588501,1,2,,26725306,23205,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
601,588511,1,2,,26725306,23205,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
602,588519,1,2,,99300642,23205,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
603,588549,1,1,,26725306,23205,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
604,588579,1,1,,26725306,23205,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
605,588579,1,1,,26756790,23205,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
606,588590,1,1,,26725306,23205,Inconclusive,154350220.0,11201.0,14.1254,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
607,588591,1,1,,26725306,23205,Inconclusive,5729982.0,5429.0,89.1251,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
608,588621,1,1,,26725306,23205,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
609,588627,1,1,,26725306,23205,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
610,588664,1,2,,26725306,23205,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
611,588664,1,2,,26725306,23205,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
612,588674,1,2,,26725306,23205,Active,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
613,588675,1,1,,26725306,23205,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
614,588676,1,1,,26725306,23205,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
615,588689,1,1,,26725306,23205,Inconclusive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
616,588692,2,1,,26725306,23205,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
617,588726,1,2,,26725306,23205,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
618,588727,1,1,,26725306,23205,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
619,588792,1,1,,26725306,23205,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
620,588794,1,1,,26725306,23205,Active,9629429.0,,,,Counterscreen for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16),Screening,,
621,588795,1,1,,26725306,23205,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
622,588814,1,3,,26725306,23205,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
623,588819,1,4,,26725306,23205,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
624,588820,1,1,,26725306,23205,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1).,Screening,,
625,588824,1,1,,26725306,23205,Active,9629429.0,,,,Counterscreen for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16).,Screening,,
626,588850,1,1,,26725306,23205,Active,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
627,588852,1,3,,26725306,23205,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
628,588855,1,1,,26725306,23205,Active,18418623.0,4088.0,3.9811,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
629,588856,1,1,,26725306,23205,Active,,,11.2202,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
630,602123,1,1,,26725306,23205,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
631,602141,1,1,,26725306,23205,Active,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
632,602162,1,1,,26725306,23205,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
633,602163,1,1,,26725306,23205,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
634,602179,1,2,,26725306,23205,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
635,602229,1,1,,26725306,23205,Active,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
636,602233,1,1,,26725306,23205,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
637,602244,1,2,,26725306,23205,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
638,602247,1,2,,26725306,23205,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
639,602248,1,2,,26725306,23205,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
640,602250,1,2,,26725306,23205,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
641,602252,1,1,,26725306,23205,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
642,602252,1,1,,26725306,23205,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
643,602261,1,1,,26725306,23205,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
644,602274,1,2,,26725306,23205,Active,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
645,602281,1,1,,26725306,23205,Active,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
646,602281,1,1,,26725306,23205,Active,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
647,602310,1,2,,26725306,23205,Inconclusive,13399304.0,60489.0,0.5623,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
648,602313,1,1,,26725306,23205,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
649,602314,1,2,,99300642,23205,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
650,602329,1,1,,26725306,23205,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
651,602332,1,1,,26725306,23205,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
652,602332,1,1,,26756790,23205,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
653,602340,1,2,,26725306,23205,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
654,602342,2,1,,26725306,23205,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
655,602346,1,1,,26725306,23205,Active,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
656,602363,1,1,,26725306,23205,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
657,602393,1,1,,26725306,23205,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
658,602396,1,2,,26725306,23205,Active,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
659,602399,1,2,,26725306,23205,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
660,602405,1,1,,26725306,23205,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
661,602410,1,1,,26725306,23205,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
662,602429,1,1,,26725306,23205,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
663,602438,1,1,,26725306,23205,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
664,602440,1,1,,26725306,23205,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
665,602449,1,2,,26725306,23205,Inactive,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
666,602481,1,1,,26725306,23205,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
667,623861,1,1,,26725306,23205,Active,,,7.88,EC50_Mean,Dose response confirmation of uHTS hits that enhance the survival of human induced pluripotent stem cells when cultured as single cells in a luminescent assay,Confirmatory,,
668,623870,1,1,,26725306,23205,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
669,623870,1,1,,26725306,23205,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
670,623877,1,1,,26725306,23205,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
671,623901,1,1,,26725306,23205,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
672,624037,1,3,,26725306,23205,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
673,624038,1,3,,26725306,23205,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
674,624040,1,3,,26725306,23205,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
675,624125,1,4,,26725306,23205,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
676,624126,1,3,,26725306,23205,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
677,624127,1,2,,26725306,23205,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
678,624132,1,1,,26725306,23205,Active,,,0.825,AC50_uM,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
679,624133,1,1,,26725306,23205,Active,,,1.53,AC50_uM,Shn3: Dual-Go Shn3RL cells Measured in Cell-Based System Using Plate Reader - 2134-02_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
680,624134,1,1,,26725306,23205,Active,,,4.35,AC50_uM,Shn3: Cytotox assay Measured in Cell-Based System Using Plate Reader - 2134-03_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
681,624145,1,1,,26725306,23205,Inactive,,,80.0,EC50_Mean,"Dose response confirmation of uHTS hits that enhance the survival of human induced pluripotent stem cells when cultured as single cells in a fluorescent-based, imaging assay",Confirmatory,,
682,624168,1,1,,26725306,23205,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
683,624169,1,1,,26725306,23205,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
684,624170,1,1,,26725306,23205,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
685,624171,1,1,,26725306,23205,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
686,624172,1,1,,26725306,23205,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
687,624173,1,3,,26725306,23205,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
688,624178,1,1,,26725306,23205,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
689,624202,1,1,,26725306,23205,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
690,624204,1,2,,26725306,23205,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
691,624246,1,1,,26725306,23205,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
692,624247,1,1,,26756790,23205,Inconclusive,116283940.0,79915.0,17.7299,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation in Cell-Based Luciferin Assay,Confirmatory,,
693,624248,1,1,,26756790,23205,Inconclusive,116283940.0,79915.0,35.3758,Potency,HTS assay for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1: Hit Confirmation,Confirmatory,,
694,624249,1,1,,26756790,23205,Active,116283940.0,79915.0,0.0045,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1: Hit Confirmation using MMS Stimulated ELG1,Confirmatory,,
695,624250,1,1,,26756790,23205,Inconclusive,116283940.0,79915.0,0.0199,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation with 5FU Viability,Confirmatory,,
696,624251,1,1,,26756790,23205,Active,116283940.0,79915.0,0.0056,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation with MMS Viability,Confirmatory,,
697,624252,1,1,,26756790,23205,Active,116283940.0,79915.0,2.81,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation with Unstimulated Viability Assay,Confirmatory,,
698,624253,1,1,,26756790,23205,Active,116283940.0,79915.0,7.308,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation in Biochemical Luciferin Assay,Confirmatory,,
699,624256,1,2,,26725306,23205,Inconclusive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
700,624263,1,1,,26725306,23205,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
701,624263,1,1,,26725306,23205,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
702,624267,1,2,,26725306,23205,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
703,624267,1,2,,26725306,23205,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
704,624268,1,3,,26725306,23205,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
705,624288,1,1,,26725306,23205,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
706,624296,1,1,,26725306,23205,Active,7705682.0,51053.0,0.92,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
707,624297,1,1,,26725306,23205,Inconclusive,7705682.0,51053.0,0.1458,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
708,624304,1,2,,26725306,23205,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
709,624330,1,2,,26725306,23205,Inactive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
710,624352,1,1,,26725306,23205,Active,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
711,624354,1,1,,26725306,23205,Active,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
712,624377,1,1,,26725306,23205,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
713,624378,1,1,,26725306,23205,Active,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
714,624379,1,1,,26725306,23205,Inactive,9629429.0,,,,"Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): Luminescence-based cell-based high throughput screening assay to identify agonists of the Herpes Virus Virion Protein 16 (VP16)",Screening,,
715,624394,1,2,,26725306,23205,Active,216409728.0,10002.0,1.921,IC50,"Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Confirmatory,,
716,624395,1,1,,26725306,23205,Active,9629429.0,,4.374,IC50,"Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3):Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16)",Confirmatory,,
717,624414,1,1,,26725306,23205,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
718,624415,1,2,,26725306,23205,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
719,624416,1,1,,26725306,23205,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
720,624417,1,1,,26725306,23205,Active,1724069.0,2740.0,2.5119,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
721,624418,1,1,,26725306,23205,Inconclusive,,,1.7783,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
722,624463,1,1,,26725306,23205,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
723,624464,1,1,,26725306,23205,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
724,624465,1,1,,26725306,23205,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
725,624466,1,3,,26725306,23205,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
726,624467,1,1,,26725306,23205,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
727,624483,1,1,,26725306,23205,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
728,651550,1,1,,26725306,23205,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
729,651560,1,1,,26725306,23205,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
730,651572,1,2,,26725306,23205,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
731,651582,1,1,,26725306,23205,Active,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
732,651602,1,1,,26725306,23205,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
733,651602,1,1,,26725306,23205,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
734,651602,1,1,,26725306,23205,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
735,651612,1,1,,26725306,23205,Active,31542303.0,51099.0,,,"Luminescence-based biochemical high throughput confirmation assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
736,651612,1,1,,26725306,23205,Active,116292172.0,440503.0,,,"Luminescence-based biochemical high throughput confirmation assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
737,651635,1,3,,26725306,23205,Active,171543895.0,6311.0,19.9526,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
738,651636,1,1,,26725306,23205,Active,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
739,651640,1,1,,26725306,23205,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
740,651644,1,1,,26725306,23205,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
741,651647,1,1,,26725306,23205,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
742,651654,1,1,,26725306,23205,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
743,651658,1,1,,26725306,23205,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
744,651661,2,1,,26725306,23205,Active,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
745,651674,1,1,,26725306,23205,Active,31077205.0,3172.0,,,"Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization",Screening,,
746,651687,1,1,,26725306,23205,Active,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
747,651699,1,1,,26725306,23205,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
748,651699,1,1,,26725306,23205,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
749,651702,1,2,,26725306,23205,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
750,651704,2,1,,26725306,23205,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
751,651710,1,1,,26725306,23205,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
752,651711,2,1,,26725306,23205,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
753,651718,1,2,,26725306,23205,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
754,651723,1,1,,26725306,23205,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity,Screening,,
755,651724,1,1,,26725306,23205,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
756,651725,1,1,,26725306,23205,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
757,651768,1,2,,26725306,23205,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
758,651800,1,1,,26725306,23205,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
759,651819,1,1,,26725306,23205,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
760,651820,1,1,,26725306,23205,Active,,,1.4125,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
761,651821,2,4,,26725306,23205,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
762,651957,1,1,,26725306,23205,Active,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
763,651958,1,1,,26725306,23205,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
764,651965,1,1,,26725306,23205,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
765,651999,1,1,,26725306,23205,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
766,652007,1,1,,26725306,23205,Active,9629429.0,,,,Counterscreen for inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16),Screening,,
767,652008,1,1,,26725306,23205,Active,5729858.0,10499.0,,,Luminescence-based cell-based high throughput confirmation assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
768,652010,1,1,,26725306,23205,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
769,652017,1,1,,26725306,23205,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
770,652025,1,1,,26725306,23205,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
771,652039,1,1,,26725306,23205,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
772,652048,1,2,,26725306,23205,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
773,652051,1,1,,26725306,23205,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
774,652054,1,1,,26725306,23205,Active,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
775,652067,1,4,,26725306,23205,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
776,652104,1,1,,26725306,23205,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
777,652105,1,1,,26725306,23205,Inactive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
778,652106,1,1,,26725306,23205,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
779,652115,1,1,,26725306,23205,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
780,652126,1,3,,26725306,23205,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
781,652154,1,1,,26725306,23205,Active,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
782,652162,2,1,,26725306,23205,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
783,652163,1,1,,26725306,23205,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
784,652197,1,1,,26725306,23205,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
785,652257,1,1,,26725306,23205,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
786,671223,2,2,,103360847,23205,Active,,,0.28,IC50,Cytotoxicity against human K562 cells assessed as growth inhibition after 48 hrs by SRB assay,Confirmatory,22574648.0,
787,671224,2,2,,103360847,23205,Active,,,0.29,IC50,Cytotoxicity against human HCT15 cells assessed as growth inhibition after 48 hrs by SRB assay,Confirmatory,22574648.0,
788,671225,2,3,,103360847,23205,Active,,,0.21,IC50,Cytotoxicity against human SKLU1 cells assessed as growth inhibition after 48 hrs by SRB assay,Confirmatory,22574648.0,
789,686933,1,2,,26756790,23205,Active,116283940.0,79915.0,7.308,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: SAR in Biochemical Luciferin Assay,Confirmatory,,
790,686934,1,2,,26756790,23205,Inconclusive,116283940.0,79915.0,17.7299,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: SAR in Cell-Based Luciferin Counter Assay,Confirmatory,,
791,686940,1,1,,26725306,23205,Active,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
792,686964,1,1,,26725306,23205,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
793,686970,1,2,,26725306,23205,Active,49168486.0,3417.0,1.4581,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
794,686971,1,2,,26725306,23205,Active,,,0.5805,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
795,686978,1,1,,26725306,23205,Inconclusive,79154014.0,55775.0,0.8199,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
796,686978,1,1,,26756790,23205,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
797,686979,1,1,,26725306,23205,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
798,686979,1,1,,26756790,23205,Inconclusive,79154014.0,55775.0,35.4813,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
799,686992,2,1,,26725306,23205,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
800,686996,1,1,,26725306,23205,Inactive,13325293.0,839.0,,,VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
801,687007,1,2,,26725306,23205,Active,9629429.0,,,,Counterscreen for antagonists of COUP-TFII (NR2F2): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16),Screening,,
802,687008,1,1,,26725306,23205,Active,14149746.0,7026.0,,,Luminescence-based cell-based high throughput confirmation assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
803,687014,1,1,,26725306,23205,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
804,687016,1,1,,26725306,23205,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
805,720504,1,1,,26725306,23205,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
806,720508,1,1,,26725306,23205,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
807,720509,1,1,,26725306,23205,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
808,720511,1,1,,26725306,23205,Active,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
809,720532,1,1,,26756790,23205,Inconclusive,420597.0,,14.1254,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
810,720533,1,1,,26756790,23205,Inconclusive,,,11.2202,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
811,720542,1,2,,26725306,23205,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
812,720543,1,1,,26725306,23205,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
813,720551,1,2,,26725306,23205,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
814,720553,1,2,,26725306,23205,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
815,720579,2,1,,26725306,23205,Inconclusive,222762.0,3707576.0,10.0,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
816,720579,2,1,,26756790,23205,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
817,720580,1,1,,26725306,23205,Active,222762.0,3707576.0,10.0,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
818,720580,1,1,,26756790,23205,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
819,720582,1,1,,26725306,23205,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
820,720596,1,1,,26725306,23205,Active,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
821,720647,1,2,,26725306,23205,Active,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
822,720648,1,1,,26725306,23205,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
823,720700,1,4,,26725306,23205,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
824,720702,1,1,,26725306,23205,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
825,720704,1,4,,26725306,23205,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
826,720706,1,2,,26725306,23205,Inactive,,,,,HTS for Bacterial rRNA inhibitors Measured in Microorganism-Based System Using Plate Reader - 7056-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
827,720707,1,2,,26725306,23205,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
828,720708,1,2,,26725306,23205,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
829,720709,1,2,,26725306,23205,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
830,720711,1,2,,26725306,23205,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
831,720717,1,3,,92309728,23205,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
832,743126,1,1,,26725306,23205,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
833,743200,1,2,,26725306,23205,Active,4506113.0,5621.0,,,TRFRET-based cell-based high throughput confirmation assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
834,743201,1,3,,26725306,23205,Active,4506113.0,5621.0,,,Counterscreen for inhibitors of cell surface Prion Protein (PrPc): Luminescence-based cell-based high throughput assay to identify compounds that are cytotoxic to LD9 cells,Screening,,
835,743238,1,1,,26725306,23205,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
836,743247,1,2,,26725306,23205,Active,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
837,743255,1,1,,26725306,23205,Inconclusive,118600387.0,7398.0,8.9125,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
838,743266,1,2,,26725306,23205,Inactive,296080761.0,5745.0,7.9433,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
839,743267,1,1,,26725306,23205,Active,89348172.0,1080.0,0.9890000000000001,AC50_uM,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_Dose_CherryPick_Activity,Confirmatory,,
840,743269,1,1,,26725306,23205,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
841,743269,1,1,,26725306,23205,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
842,743279,1,2,,26725306,23205,Active,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
843,743287,1,1,,26725306,23205,Inactive,,,,,Luminescent GLuc Reporter Gene Assay Primary HTS to Identify Small Molecule Activator of Glucose Dependent Insulin Secretion Measured in Cell-Based System Using Plate Reader - 7055-01_Activator_SinglePoint_HTS_Activity,Screening,,
844,743395,1,1,,26725306,23205,Active,,,2.99,AbsAC35_uM,HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Other_Dose_CherryPick_Activity_Set2,Confirmatory,,
845,743397,1,1,,26725306,23205,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
846,743398,1,1,,26725306,23205,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
847,743402,1,1,,26725306,23205,Active,,,5.32,AbsAC35_uM,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Fischer Rat Thyroid (FRT) Cells. Measured in Cell-Based System Using Plate Reader - 7017-02_Other_Dose_CherryPick_Activity,Confirmatory,,
848,743417,1,1,,26725306,23205,Active,,,0.825,AC50_uM,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_DryPowder_Activity_Set2,Confirmatory,,
849,746037,1,2,,103360847,23205,Active,,,21.11,IC50,Cytotoxicity against chicken HD11 cells assessed as cell viability after 24 hrs by MTS assay,Confirmatory,23501116.0,
850,746038,3,2,,103360847,23205,Active,127591.0,396244.0,2.37137,IC50,Inhibition of c-Myb-induced mim-1 gene expression in doxycyclin-treated chicken HD11 cells after 24 hrs by GFP assay,Confirmatory,23501116.0,
851,1035475,1,1,,172541524,23205,Inactive,,,,AC50_uM,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
852,1053117,1,1,,172541524,23205,Inactive,,,,AC50_uM,HEK293 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-01_Inhibitor_Dose_CherryPick_Activity_Set5,Confirmatory,,
853,1053118,1,1,,172541524,23205,Inactive,,,,AC50_uM,HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_CherryPick_Activity_Set5,Confirmatory,,
854,1053119,1,1,,172541524,23205,Inactive,,,,AC50_uM,A549 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-06_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
855,1053197,1,1,,26725306,23205,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
856,1117283,1,1,,172541524,23205,Inactive,,,,AC50_uM,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_Dose_CherryPick_Activity_Set2,Confirmatory,,
857,1117319,1,2,,26725306,23205,Inactive,9629361.0,155459.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
858,1117319,1,2,,26725306,23205,Inactive,13399304.0,60489.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
859,1120836,1,1,,103360847,23205,Unspecified,,,,,Antitumor activity against mouse P388 cells allografted in DBA/2 mouse assessed as survival,Other,,
860,1120837,1,1,,103360847,23205,Unspecified,,,,,Antiproliferative activity against human Hep2 cells,Other,,
861,1132871,1,1,,103360847,23205,Unspecified,,,,,Toxicity in Sprague-Dawley rat allografted with rat Walker 256 cells assessed as mortality after 4 days,Other,671468.0,
862,1132872,1,1,,103360847,23205,Unspecified,,,,,Cytotoxicity against human Hep2 cells assessed as growth inhibition by microtiter method,Other,671468.0,
863,1132873,1,1,,103360847,23205,Unspecified,,,,,Antitumor activity against mouse P388 cells allografted in DBA/2 mouse assessed as survival rate at 16.8 mg/kg relative to control,Other,671468.0,
864,1132878,1,1,,103360847,23205,Unspecified,,,,,Toxicity in DBA/2 mouse allografted with mouse P388 cells assessed as mortality after 4 days,Other,671468.0,
865,1132879,1,1,,103360847,23205,Unspecified,,,,,Antitumor activity against rat Walker 256 cells allografted in Sprague-Dawley rat assessed as survival rate at 2.5 mg/kg relative to control,Other,671468.0,
866,1132951,1,1,,103360847,23205,Unspecified,,,,,Cytotoxicity against human Hep2 cells assessed a growth inhibition by rapid microtiter technique,Other,691008.0,
867,1132952,1,1,,103360847,23205,Unspecified,,,,,"Antitumor activity against mouse P388 cells allografted in DBA/2 mouse assessed as increase in survival rate at 16.8 mg/kg/day, ip administered for 2 weeks relative to control",Other,691008.0,
868,1132956,1,1,,103360847,23205,Unspecified,,,,,"Antitumor activity against mouse Walker 256 cells allografted in Sprague-Dawley rat assessed as increase in survival rate at 2.5 mg/kg/day, ip relative to control",Other,691008.0,
869,1149567,1,1,,103360847,23205,Unspecified,,,,,"Antitumor activity against mouse EAC cells allografted in CF1 mouse assessed as tumor growth inhibition at 33.3 mg/kg/day, ip after 7 days",Other,845864.0,
870,1149568,1,1,,103360847,23205,Unspecified,,,,,"Antitumor activity against rat Walker 256 cells allografted in Sprague-Dawley rat at 2.5 mg/kg/day, ip relative to control",Other,845864.0,
871,1149569,1,1,,103360847,23205,Unspecified,,,,,"Antitumor activity against mouse P388 cells allografted in DBA/2 mouse at 25 mg/kg/day, ip relative to control",Other,845864.0,
872,1149570,1,1,,103360847,23205,Unspecified,,,,,Cytotoxicity against human Hep2 cells,Other,845864.0,
873,1149571,1,1,,103360847,23205,Inactive,,,,,Binding affinity to dGMP (unknown origin) at 0.015 ug at pH 7.2 after 24 hrs by UV-spectrophotometry,Other,845864.0,
874,1149572,1,1,,103360847,23205,Inactive,,,,,Binding affinity to dGTP (unknown origin) at 0.015 ug at pH 7.2 after 24 hrs by UV-spectrophotometry,Other,845864.0,
875,1149573,1,1,,103360847,23205,Inactive,,,,,Binding affinity to dAMP (unknown origin) at 0.015 ug by UV-spectrophotometry,Other,845864.0,
876,1149574,1,1,,103360847,23205,Inactive,,,,,Binding affinity to dATP (unknown origin) at 0.015 ug by UV-spectrophotometry,Other,845864.0,
877,1149575,1,1,,103360847,23205,Inactive,,,,,Binding affinity to DNA (unknown origin) at 0.015 ug at pH 7.2 after 24 hrs by UV-spectrophotometry,Other,845864.0,
878,1149576,1,1,,103360847,23205,Inactive,,,,,Binding affinity to dGMP (unknown origin) by NMR analysis,Other,845864.0,
879,1149577,1,1,,103360847,23205,Unspecified,,,,,Stability of the compound assessed as reactivity with oxidized glutathione at 10 mg after 4 hrs by NMR analysis,Other,845864.0,
880,1149578,1,1,,103360847,23205,Active,,,,,Stability of the compound assessed as reactivity with reduced glutathione at 10 mg after 4 hrs by NMR analysis,Other,845864.0,
881,1149579,1,1,,103360847,23205,Active,,,,,Stability of the compound assessed as reactivity with L-cysteine at 10 mg after 4 hrs by NMR analysis,Other,845864.0,
882,1149583,1,1,,103360847,23205,Unspecified,,,,,Antitumor activity against mouse EAC cells allografted in CF1 mouse assessed as DNA content at 0.125 mg/day administered from day 5 to day 7 measured on day 8 by UV-spectrophotometry relative to control,Other,845864.0,
883,1149585,1,1,,103360847,23205,Unspecified,,,,,Antitumor activity against mouse EAC cells allografted in CF1 mouse assessed as chromatin protein content at 0.125 mg/day administered from day 5 to day 7 measured on day 8 relative to control,Other,845864.0,
884,1149587,1,1,,103360847,23205,Unspecified,,,,,Antitumor activity against mouse EAC cells allografted in CF1 mouse assessed as [methyl-14C]thymidine incorporation to DNA at 0.125 mg/day administered from day 5 to day 7 measured on day 8 by scintillation counting analysis relative to control,Other,845864.0,
885,1149589,1,1,,103360847,23205,Unspecified,,,,,Antitumor activity against mouse EAC cells allografted in CF1 mouse assessed as nuclear DNA polymerase activity at 0.125 mg/day administered from day 5 to day 7 measured on day 8 relative to control,Other,845864.0,
886,1149591,1,1,,103360847,23205,Unspecified,,,,,Antitumor activity against mouse EAC cells allografted in CF1 mouse assessed as free lysosomal DNAse activity at 0.125 mg/day administered from day 5 to day 7 measured on day 8 relative to control,Other,845864.0,
887,1149593,1,1,,103360847,23205,Unspecified,,,,,Antitumor activity against mouse EAC cells allografted in CF1 mouse assessed as [gamma-32P] incorporation into histone at 0.125 mg/day administered from day 5 to day 7 measured on day 8 relative to control,Other,845864.0,
888,1149595,1,1,,103360847,23205,Unspecified,,,,,Antitumor activity against mouse EAC cells allografted in CF1 mouse assessed as [gamma-32P] incorporation into nonhistone at 0.125 mg/day administered from day 5 to day 7 measured on day 8 relative to control,Other,845864.0,
889,1149596,1,1,,103360847,23205,Unspecified,,,,,"Antitumor activity against mouse EAC cells allografted in CF1 mouse assessed as 3',5' cAMP level at 0.125 mg/day administered from day 5 to day 7 measured on day 8 by RIA relative to control",Other,845864.0,
890,1149598,1,1,,103360847,23205,Unspecified,,,,,Antitumor activity against mouse EAC cells allografted in CF1 mouse assessed as ascitocrit count per mililitre of fluid at 0.125 mg/day administered from day 5 to day 7 measured on day 8 by hemocytometry relative to control,Other,845864.0,
891,1149600,1,1,,103360847,23205,Unspecified,,,,,Antitumor activity against mouse EAC cells assessed as nuclear DNA polymerase activity at 0.6 mg measured on day 8 relative to control,Other,845864.0,
892,1149601,1,1,,103360847,23205,Unspecified,,,,,Antitumor activity against mouse EAC cells assessed as tissue SH stimulation at 0.6 mg measured on day 8 by Ellman method relative to control,Other,845864.0,
893,1149602,1,1,,103360847,23205,Inactive,,,,,Antitumor activity against mouse EAC cells allografted in CF1 mouse assessed as cell viability at 0.125 mg/day administered from day 5 to day 7 measured on day 8 by trypan blue assay relative to control,Other,845864.0,
894,1159524,1,1,,26725306,23205,Active,,,8.9125,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
895,1159524,1,1,,26756790,23205,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
896,1159606,1,1,,26725306,23205,Active,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
897,1159972,1,2,,103360847,23205,Active,6226780.0,7015.0,4.0,IC50,Inhibition of telomerase in human HL60 cells by TRAP assay,Confirmatory,,
898,1159973,1,2,,103360847,23205,Active,6226780.0,7015.0,4.0,IC50,Inhibition of telomerase in human Jurkat cells by TRAP assay,Confirmatory,,
899,1159974,1,1,,103360847,23205,Unspecified,,,,,Cytotoxicity against human Hep2 cells assessed as growth inhibition,Other,,
900,1224865,1,2,,26725306,23205,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
901,1259313,1,1,,26725306,23205,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
902,1259318,1,1,,26725306,23205,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
903,1259408,1,1,,363896485,23205,Inactive,,,,,GENE-TOX mutagenicity studies,Other,,
904,1259415,1,1,,26725306,23205,Active,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
